Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility [Phase 3]

View source ↗

Summary

This document describes a Phase 3 clinical trial comparing landiolol to standard of care for preventing mortality in patients with septic shock and hypercontrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LANdiolol (landiolol hydrochloride)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Septic Shock, Tachycardia | Phase 3 | Status: RECRUITING